John Schier, DMD
Oral and Maxillofacial Surgery · Indianapolis, INNPI 1932440054
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.5%), education and entertainment — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Straumann USA LLC at 58.9% of the total. Reporting peaked in 2021 at $809 and has fallen 85.2% since, to $119 in 2025.
Across 22 payments — averaging $74.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Straumann USA LLC$963
- Kls-martin L.p.$436
- Colgate Oral Pharmaceuticals, Inc.$79
- Keystone Dental Inc.$55
- Nobel Biocare USA$46
- Geistlich Pharma, North America, Inc.$36
- plus $19 from 1 others
What the payments were for
- Food & beverage$87554%
- Education$70443%
- Entertainment$553%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Straumann USA LLC | 10 | $963 |
| Kls-martin L.p. | 6 | $436 |
| Colgate Oral Pharmaceuticals, Inc. | 1 | $79 |
| Keystone Dental Inc. | 1 | $55 |
| Nobel Biocare USA | 1 | $46 |
| Geistlich Pharma, North America, Inc. | 2 | $36 |
| Johnson & Johnson | 1 | $19 |
How this compares
$1,634 in reported general payments places this provider in the 80th percentile of 127 oral and maxillofacial surgery providers in Indiana.
See all oral and maxillofacial surgery providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Moxifloxacin Hcl | 12 | $574 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 115 | $517 |
| Ibuprofen | 143 | $437 |
| Amoxicillin | 151 | $420 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 50 | $288 |
| Clindamycin Hcl | 28 | $197 |
| Chlorhexidine Gluconate | 51 | $133 |
| Tramadol Hcl | 35 | $79 |
| IbuIbuprofen | 24 | $44 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Indianapolis
- Waldemar PolidoIndianapolis$145K
- Timothy SurberIndianapolis$14K
- Charles AbrahamIndianapolis$5K
- Patrick KellyIndianapolis$5K
- Christopher BurnsIndianapolis$4K
- Nicholas WegnerIndianapolis$3K
- Paramjeet SagooIndianapolis$2K
- Mark McDonoughIndianapolis$2K
- Nikolas WasylykIndianapolis$2K
- Robinpreet PannuIndianapolis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.